Related Experiment Video
Updated: Jun 10, 2026

09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Inflammation and survival pathways: chronic lymphocytic leukemia as a model system
Lisa S Chen1, Kumudha Balakrishnan, Varsha Gandhi
1Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4095, USA.
Biochemical Pharmacology
|August 11, 2010
Summary
Inflammation increases cell survival via anti-apoptotic Bcl-2 proteins and Pim kinases. These pathways, crucial in chronic lymphocytic leukemia (CLL), offer survival advantages and are targeted by new cancer drugs.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Inflammation triggers cell survival mechanisms, primarily through anti-apoptotic Bcl-2 family proteins.
- The Pim kinase pathway also contributes to cell survival, influencing transcription, cell cycle, and protein degradation.
Purpose of the Study:
- To elucidate the mechanisms by which Bcl-2 family proteins and Pim kinases promote cell survival.
- To investigate these pathways in chronic lymphocytic leukemia (CLL) as an optimal model.
- To understand the role of microenvironment and stromal support in inducing pro-survival proteins in CLL.
Main Methods:
- Analysis of transcript and protein levels of anti-apoptotic Bcl-2 family members.
- Investigation of post-translational modifications affecting protein stability.
- Examination of Pim-mediated phosphorylation of pro-apoptotic proteins.
- Assessment of cross-talk between Bcl-2 and Pim pathways in CLL cells with stromal support.
Main Results:
- Multiple mechanisms increase Bcl-2 family protein levels and stability.
- Pim kinase activity inhibits pro-apoptotic proteins.
- Cross-talk between Bcl-2 and Pim pathways enhances CLL cell survival and maintenance.
- Stromal support contributes to the induction of pro-survival proteins.
Conclusions:
- Bcl-2 family proteins and Pim kinases are key mediators of cell survival in inflammation and hematological malignancies like CLL.
- The interplay between these pathways, influenced by the microenvironment, is critical for disease maintenance.
- Pharmacological inhibitors targeting these pathways are under development for treating hematological malignancies.
Related Concept Videos
Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

